key: cord-0824849-l8o76x4f
authors: Ahmad, Habab Ali; Khan, Haleema; Shahzad, Muhammad; Haq, Zia ul; Harake, Steve; Yousafzai, Yasar Mehmood
title: Suspected reinfections of SARS-COV-2 in Khyber Pakhtunkhwa, Pakistan – analysis of province-wide testing database
date: 2021-10-09
journal: J Infect
DOI: 10.1016/j.jinf.2021.10.005
sha: f9552351e0f3545449a6d2696a7dab2595c3cb85
doc_id: 824849
cord_uid: l8o76x4f

nan

2 reinfection as a second positive real time reverse transcription-polymerase chain reaction (RT-PCR) test, taken ≥90 days after the primary result (9) . However, not all published work follows a uniformly set criteria for what constitutes confirmed reinfection.

Studies which follow the CDC criteria indicate high level of protection following recovery from infection, with reinfection suspected in less than 1.0% of those previously infected (2, [5] [6] [7] [8] . However, further detailed prospective studies are needed to assess frequency of recurring infection. There is a possibility that a large proportion of reinfections are undetected, which could explain the low risk of SARS-CoV-2 reinfection reported in literature. This may especially be true in lower-middleincome settings, such as ours, where testing for asymptomatic infection is rare, and carrying out mass-scale genomic sequencing is not always logistically feasible.

Pakistan is currently experiencing a fourth epidemic wave of SARS-CoV-2 transmission. This provided us an opportunity to retrospectively determine incidence of suspected reinfections after three global waves in the pandemic. Using epidemiological criteria set by CDC, we undertook this study to identify suspected cases of SARS-CoV-2 reinfection, in the province of Khyber Pakhtunkhwa (KP), using the provincial government's contact tracing database.

This descriptive cross-sectional study was approved by the Khyber Medical University (KMU) Ethical Committee. Due to retrospective nature of our analysis, we were granted a waiver from obtaining informed consent.

In KP, testing has been extended to symptomatic and suspected cases, those presenting at hospitals, people identified through contact tracing, contacts of confirmed cases, people with travel history, or anyone using the free COVID-19 response hotline. Samples are sent to one of the 28 public and We extracted retrospective data for all SARS-CoV-2 RT-PCR tests carried out from March, 2020, to July, 2021, in KP. For purpose of this study, primary infection was defined as a positive RT-PCR test for SARS-CoV-2. Suspected reinfection was defined as a second positive test taken for SARS-CoV-2, ≥90 days after the primary positive test result. Analyses were performed using MS Excel.

Comparison between demographic variables of primary infections and suspected reinfections were made using Chi-square test.

Between March 2020 to July 2021, a total of 2,065,611 SARS-CoV-2 RT-PCR tests were conduct- (Table 1) .

These findings suggest that SARS-CoV-2 reinfection could be common in age groups often presumed less likely to suffer from severe, or critical COVID-19. This is in contradiction to evidence which shows symptomatic COVID-19 results in enhanced, long-lasting protective immunity following recovery from primary infection (10) . Our results reveal that more than two thirds (73.1%) of recurring infections were picked up through hospital referrals, which could indicate that people with severe symptoms are more likely to seek medical attention.

Studies have demonstrated that a large proportion of recurring infections are asymptomatic, and reinfection is more common in individuals whose primary infections were also asymptomatic (1, 7).

In Pakistan, the testing strategy has largely relied on targeting of symptomatic and suspected cases. Therefore, it is impossible to accurately predict the true number of SARS-CoV-2 reinfections, which may be significantly larger than what has been reported in literature.

There were several limitations to this work. Since data was gathered retrospectively, we were unable to obtain medical history, clinical demographics, or personal details, regarding individuals whose test results were utilised in our analysis. Thus, we could not correlate role of any pre-existing health conditions with suspected reinfection. Similarly, the proportion of individuals employed in high-risk professions, such as healthcare workers, was unknown. Our future work aims to address these limitations. To best of our knowledge, this is the largest multi-centre analysis (n=142,787) of its kind carried out to date, reporting one of the highest event-rates (317 suspected reinfections) in published literature (6) . Our results fall within range of reinfections reported in literature, despite limited testing being carried out in Pakistan for identification of asymptomatic cases. This analysis suggests that recurring infection with SARS-CoV-2 may indeed be a widespread phenomenon, although the risk is known to be low. 

Prior COVID-19 protects against reinfection, even in the absence of detectable antibodies

Rates of recurrent positive SARS-CoV-2 swab results among patients attending primary care in Qatar

Prior SARS-CoV-2 infection is associated with protection against symptomatic reinfection

Assessment of protection against reinfection with SARS-CoV-2 among 4 million PCR-tested individuals in Denmark in 2020: a population-level observational study

Suspected SARS-CoV-2 Reinfections: Incidence, Predictors, and Healthcare Use among Patients at 238 U.S. Healthcare Facilities

Reinfection or Reactivation of Severe Acute Respiratory Syndrome Coronavirus 2: A Systematic Review

Assessment of SARS-CoV-2 Reinfection 1 Year After Primary Infection in a Population in

html#print: Centers for Disease Control and Prevention

SARS-CoV-2 antibody magnitude and detectability are driven by disease severity, timing, and assay